Medicare Enrolled

Dr. Rosy Rajbhandary, MD

Rheumatology · Burleson, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
11803 SOUTH FWY, Burleson, TX 76028
8172932944
In practice since 2010 (15 years)
NPI: 1154641587 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rajbhandary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rajbhandary? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rajbhandary

Dr. Rosy Rajbhandary is a rheumatology in Burleson, TX, with 15 years in practice. Based on federal Medicare data, Dr. Rajbhandary performed 913 Medicare services across 543 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rajbhandary received a total of $12,172 from 37 pharmaceutical and/or device companies across 769 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rajbhandary is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ 913 Medicare services$ $12,172 industry payments

Medicare Practice Summary

Medicare Utilization ↗
913
Medicare services
Bottom 43% in TX for rheumatology
543
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~61 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)612$82$390
New patient office visit (45-59 min)96$113$508
Injection, methylprednisolone acetate, 40 mg59$5$17
Drug injection, under skin or into muscle47$10$42
Injection, methylprednisolone acetate, 80 mg38$8$32
Joint injection, major joint23$41$197
Injection into tendon at attachment to bone or muscle19$38$175
Aspiration and/or injection of fluid from small joint19$38$159
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,172
Total received (2018-2024)
Avg $1,739/year across 7 years
Top 28% in TX for rheumatology
37
Companies
769
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,020 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$152 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,470
2023
$2,743
2022
$2,728
2021
$1,808
2020
$822
2019
$685
2018
$916

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,843
ABBVIE INC.
$1,414
PFIZER INC.
$1,192
UCB, Inc.
$1,187
GlaxoSmithKline, LLC.
$916
Janssen Biotech, Inc.
$801
AbbVie Inc.
$656
Novartis Pharmaceuticals Corporation
$588
Hikma Pharmaceuticals USA
$569
Horizon Therapeutics plc
$568
E.R. Squibb & Sons, L.L.C.
$291
Lilly USA, LLC
$260
AstraZeneca Pharmaceuticals LP
$252
AbbVie, Inc.
$233
West-Ward Pharmaceuticals
$228
Genentech USA, Inc.
$199
Fresenius Kabi USA, LLC
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$153
Sandoz Inc.
$79
Shield Therapeutics Inc
$73
Radius Health, Inc.
$62
Celltrion USA Inc.
$55
Aurinia Pharma U.S., Inc.
$52
ANI Pharmaceuticals, Inc.
$51
GENZYME CORPORATION
$41
SHIELD THERAPEUTICS INC
$37
SCILEX PHARMACEUTICALS INC.
$24
Horizon Pharma plc
$24
Shire North American Group Inc
$20
Celgene Corporation
$19
DePuy Synthes Sales Inc.
$17
TerSera Therapeutics LLC
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
Kiniksa Pharmaceuticals International, plc
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
SOBI, INC
$13
Alexion Pharmaceuticals, Inc.
$12
Top 3 companies account for 36.6% of total payments
Associated products mentioned in payments ›
ACCRUFER · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · EVENITY · EVUSHELD · Enbrel · FORTEO · GLOPERBA · HUMIRA · HYRIMOZ · Humira · IDACIO · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PAXLOVID · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QMIIZ ODT · RAYOS · RELISTOR · RINVOQ · Rinvoq · Rituxan · Ryaltris · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tymlos · Uloric · Ultomiris · VPRIV · XELJANZ · YUFLYMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,333 per 100 Medicare services performed
Looking for a rheumatology in Burleson?
Compare rheumatologys in the Burleson area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
20
Per 100K population
10.6
County median income
$81,826
Nearest hospital
BAYLOR SCOTT AND WHITE EMERGENCY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rajbhandary is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rajbhandary experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rajbhandary performed 612 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rajbhandary receive payments from pharmaceutical companies?
Yes. Dr. Rajbhandary received a total of $12,172 from 37 companies across 769 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rajbhandary's costs compare to other rheumatologys in Burleson?
Dr. Rajbhandary's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rajbhandary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →